Long M. Luu

Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.

Kali A. Miller, A. Baranger, S. Zimmerman, 2013, Journal of medicinal chemistry.

Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.

S. Butcher, M. Tonelli, J. Vergara, 2020, Biochemistry.

Versatile Target-Guided Screen for Discovering Bidirectional Transcription Inhibitors of a Trinucleotide Repeat Disease.

J. Vergara, S. Zimmerman, Lauren D Hagler, 2021, ACS medicinal chemistry letters.

A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy

H. Chan, P. Hergenrother, S. Zimmerman, 2016, ChemMedChem.

Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.

H. Chan, S. Zimmerman, Lien Nguyen, 2015, Journal of the American Chemical Society.

A multidisciplinary approach for treating congenitally transposed canines: a clinical report.

L. Jahangiri, Long M. Luu, D. Estafan, 2006, The Journal of prosthetic dentistry.

Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor

A. Baranger, W. Chan, H. Tsoi, 2014, Journal of the American Chemical Society.

Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1

H. Chan, S. Zimmerman, A. Kalsotra, 2019, Proceedings of the National Academy of Sciences.